Huiru Li

Huiru Li

Auto-generated profile, based on publicly available information

Huiru Li

SCNU Environmental Research Institute, Guangdong Provincial Key Laboratory of Chemical Pollution and Environmental Safety & MOE Key Laboratory of Theoretical Chemistry of Environment, South China Normal University, Guangzhou, 510006, China; School of Environment, South China Normal University, Guangzhou, 510006, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2024 in Environmental Research
Verified
Journal Article
Closed access
ZLZhi-Lang Lao
Zhi-Lang Lao
DWDan Wu
Dan Wu
HLHui-Ru Li
Hui-Ru Li
YFYu-Fei Feng
Yu-Fei Feng
LZlongwei zhang
longwei zhang
JHJunjie Hu
Junjie Hu

12 March 2022 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
SLSenlin Li
Senlin Li
SCSiyu Chen
Siyu Chen
ZDZhihui Dong Zhihui Dong
Zhihui Dong Zhihui Dong
XSXingdong Song
Xingdong Song
XLXiuling Li
Xiuling Li
LZLei Zhang
Lei Zhang
Platinum-based chemotherapy resistance is a key factor of poor prognosis and recurrence in hepatocellular carcinoma (HCC). Herein, RNAseq analysis revealed that elevated tubulin folding cofactor E (TBCE) expression is associated with platinum-based chemotherapy resistance. High expression of TBCE contributes to worse prognoses and earlier recurrence among liver cancer patients. Mechanistically, TBCE silencing significantly affects cytoskeleton rearrangement, which in turn increases cisplatin-induced cycle arrest and apoptosis. To develop these findings into potential therapeutic drugs, endosomal pH-responsive nanoparticles (NPs) were developed to simultaneously encapsulate TBCE siRNA and cisplatin (DDP) to reverse this phenomena. NPs (siTBCE + DDP) concurrently silenced TBCE expression, increased cell sensitivity to platinum treatment, and subsequently resulted in superior anti-tumor effects both in vitro and in vivo in orthotopic and patient-derived xenograft (PDX) models. Taken together, NP-mediated delivery and the co-treatment of siTBCE + DDP proved to be effective in reversing chemotherapy resistance of DDP in multiple tumor models.

20 November 2025 in Geoderma
Verified
Journal Article
Open access
JXJiahong Xu
Jiahong Xu
HLHuiru Li
Huiru Li
XZXueyong Zou
Xueyong Zou
XGXiaomeng Geng
Xiaomeng Geng